Results and Discussion
Compound 1 was obtained as white powder. The HRTOF-ESIMS ion signal at m/z 525.3180 [M + Na] + (calcd for 525.3192) indicated the molecular formula C 30 H 46 O 6 with eight degrees of unsaturation. Its IR spectra showed the presence of hydroxy (3438 cm −1 ) and carbonyl functional groups (1707 cm −1 ). The 1 H and 13 C NMR data for 1 (▶ Table 1 ) were similar to those of cimiheraclein D (5) [6] , and the slight difference indicated that compound 1 was a configurational isomer of 5, which was confirmed by its 2D NMR spectra (HSQC, 1 H-1 H COSY, and HMBC) (▶ Fig. 2) . The ROESY correlations of H-23 to H-20 and of H-20 to Me-18 suggested a 23R configuration in compound 5, while the correlations of H-23 to H-17 and of H-17 to Me-28 suggested a 23S configuration in compound 1 (▶ Fig. 3 ). In addition, the configuration of C-24 in compound 5 was proposed to be S by comparison of the chemical shifts and coupling constants of H-23 (5.07, d, J = 11.2) and H-24 (3.76, s) of 5 with 23R, 24S configuration analogue [H-23 (5.01, d, J = 11.1 Hz), H-24 (3.70, s)] [8] . The configuration at C-24 in 1 was finally confirmed by molecular modeling, in which θ = 73.8°in 23R 24S configuration, θ = 177.7°in 23R 24R configuration, θ = 168.9°in 23S 24R configuration, and θ = 61.1°in 23S 24S configuration ( Fig. 10S, Supporting Information) , the coupling constants of H-23 and H-24 were 10.9 Hz and 0 Hz, so the configuration of C-24 in 1 was proposed as S based on the function of dihedral angle and 3 J H-C-C-H . Also, this was consistent with other 15,16-seco-cycloartane derivatives reported previously [5] [6] [7] [8] [9] [10] . Therefore, the structure of 1 was established as 15,16-seco-14-formyl-(23S, 24S)-16-oxohydroshengmanol-3-one (▶ Fig. 1 , which is characteristic of a 9,19-cyclolanostane-type triterpene glycoside. The sugar obtained after acid hydrolysis was identified as L-arabinose by comparing its TLC mobility and specific rotation with those of a standard. Detailed analysis of its NMR data (▶ Table 2 ) indicated that 2 is a 16α-hydroxyl dahurinol-type triterpene glycoside and is similar to cimidahuside C [20] . The major difference was the acetyl substituent. The observed 1 H-1 H COSY correlation of δ H 4.28 (1H, m, H-5′) to δ H 5.26 (1H, brs, H-4′) and the HMBC correlation between δ H 5.26 (1H, brs, H-4′) and δ H 171.2 (-OAc) indicated the acetyl group was located at C-4′ of the sugar moiety (▶ Fig. 2 ). The significant ROESY associations (▶ Fig. 3 ) of H-3/H-5 and H-20/H-17 suggested a 3S, 23R configuration. The hydroxyl group at C-24 was confirmed as S by comparison of the chemical shifts and coupling constant of 2 with those of cimidahuside C [20] . Accordingly, the structure of 2 was determined as 16α- Fig. 1 ) and named as cimiheraclein F.
Compound 3 was isolated as a white powder and found to have the molecular formula C 31 H 46 O 7 on the basis of the HRTOF-ESIMS ion peak at m/z 553.3138 [M + Na] + (calcd for 553.3141). The NMR data (▶ Table 2 ) of 3 were very similar to those of 3β,11β-dihydroxy-24,25,26,27-tetranor-cycloart-7-en-23,16β-olide 3-O-β-D-xylopyranoside [21] except for the absence of the hydroxy group at C-11. The stereochemistry of 3 was determined from its ROESY spectrum (▶ Fig. 3 ). The crosspeaks of H-3 (δ H 3.50, 1H, dd, J = 11.7, 4.1 Hz) with H-5 (δ H 1.26, 1H, dd, J = 12.5, 5.1 Hz) and H-16 (δ H 4.88, 1H, m) with H-17 (δ H 1.92, 1H) and CH 3 -28 (δ H 1.06, 3H, s) indicated the β-orientation of the substituents at C-3 and C-16. Therefore, 3 was elucidated as 3β-hydroxy-24, 25, 26, 27-tetranor-cycloart-7(8)-en-23,16β-olide 3-O-β-D-xylopyranoside (▶ Fig. 1 ) and given the name cimiheraclein G.
Compound 4 was also obtained as a white powder, and its molecular formula was C 39 H 58 O 11 based on its HRTOF-ESIMS ion signal at m/z 725.3877 [M + Na] + (calcd for 725.3877), which corresponds to 11 degrees of unsaturation. The NMR spectrum of 4 clearly displayed the signals characteristic of a 9,19-cycloartanetype triterpene. Direct analysis of its NMR data (▶ Table 2 Fig. 1 ).
The new compounds (1-4) were evaluated for their cytotoxicities against HL-60, SMMC-7721, A549, MCF-7, and SW480 cell lines (▶ Table 3 ). Compounds 1 and 2 did not show cytotoxic activity with IC 50 value > 40 µM. Compound 3 showed weak activity against A549 and MCF-7 cell lines with IC 50 value 27.75 and 22.45 µM, respectively. Compound 4 also showed antitumor activity against the HL-60, A549, and MCF-7 cell lines with IC 50 value 26.54, 36.98, and 21.34 µM, respectively.
The NMR, IR, UV, and HRTOF-ESIMS spectra of compounds 1-5, as well as the dose-response curves of cytotoxic activity, are available as Supporting Information.
▶ Table 1 The NMR data of compounds 1 and 5 (δ in ppm). ▶ Fig. 2 Major HMBC (→) and 1 H-1 H COSY (-) correlations of compounds 1-4.
Position
▶ Fig. 3 Key ROESY correlations of compounds 1-4.
▶ Table 2 The NMR data of compounds 2-4 (δ in ppm, J in Hz). 
Extraction and isolation
The air-dried and powdered aerial parts of A. heracleifolia 
Biological assays
Cytotoxic activity was investigated using five human cancer cell lines, human leukemia HL-60, hepatocellular carcinoma SMMC-7721, lung cancer A549, breast cancer MCF-7, and colon cancer SW480 (Cell Bank of Chinese Academy of Sciences). Cells were cultured at 37°C in a humidified atmosphere of 5 % CO 2 in RPMI-1640 medium (HyClone) supplemented with 10 % (v/v) FBS (HyClone) and dispersed in identical 96-well plates. Compounds were dissolved in DMSO and serially diluted in saline to give final DMSO concentrations below 1 %. Each tumor cell line was exposed to the test compounds at concentrations of 0.064, 0.32, 1.6, 8, and 40 µM for 48 h with cisplatin (DPP; Sigma, > 98 %) as the positive control; cell viability was determined by MTT cytotoxicity assay by measuring the absorbance at 570 nm with a microplate reader (Bio-Rad 680) [23] . Three independent trials were conducted for each compound (n = 3). The IC 50 values and 95 % confidence interval (CI) were estimated using GraphPad Prism 6.
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